Episode

FDA Approves Emergency Screwworm Treatment for Pets

Podcast
California News Today | 2 Min News | The Daily News Now!
Published
Jun 13, 2026
Duration seconds
106
Processing state
not_requested
Canonical source
https://api.fastcast.ai/audio/e5e6c689-32cb-44d6-bbe2-9bff83bc729f.mp3
Audio
https://api.fastcast.ai/audio/e5e6c689-32cb-44d6-bbe2-9bff83bc729f.mp3
JSON
/v1/public/podcasts/california-news-today-2-min-news-the-daily-news-now-7610473/episodes/fda-approves-emergency-screwworm-treatment-for-pets
Markdown
/podcast/california-news-today-2-min-news-the-daily-news-now-7610473/fda-approves-emergency-screwworm-treatment-for-pets.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/california-news-today-2-min-news-the-daily-news-now-7610473/episodes/fda-approves-emergency-screwworm-treatment-for-pets/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/california-news-today-2-min-news-the-daily-news-now-7610473/fda-approves-emergency-screwworm-treatment-for-pets.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

FDA just approved emergency use of nitenpyram, an over-the-counter flea drug, to fight deadly New World screwworms in dogs and cats. With 9 confirmed cases in Texas and New Mexico, this parasite — which lays eggs in open wounds and feeds on live tissue — is making a dangerous comeback. Originally approved in 2000, nitenpyram has proven effective in Brazil and now offers a critical tool for vets and pet owners. Treatments require a minimum weight and age, kill larvae within hours, but may need follow-up doses or manual removal. It doesn’t prevent future infestations — so vigilance and quick action are key to stopping the spread. Support the show: Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN: [email protected] This is an automated, high-level news summary based on public reporting. Report issues to [email protected]. View sources & latest updates: https://sources.thednn.ai/dbe7de48fb764665